|
Name |
cis-2-Thujen-4-ol
|
Molecular Formula | C10H16O | |
IUPAC Name* |
2-methyl-5-propan-2-ylbicyclo[3.1.0]hex-3-en-2-ol
|
|
SMILES |
CC(C)C12CC1C(C=C2)(C)O
|
|
InChI |
InChI=1S/C10H16O/c1-7(2)10-5-4-9(3,11)8(10)6-10/h4-5,7-8,11H,6H2,1-3H3
|
|
InChIKey |
MSEVJTQZWWZGMP-UHFFFAOYSA-N
|
|
Synonyms |
cis-2-Thujen-4-ol; 2-Thujen-4-ol; Thuja-2-ene-4-ol; 2-methyl-5-propan-2-ylbicyclo[3.1.0]hex-3-en-2-ol; SCHEMBL11519419; CHEBI:171917; DTXSID401317591; 5-Isopropyl-2-methylbicyclo[3.1.0]hex-3-en-2-ol #; 2-methyl-5-(1-methylethyl)-bicyclo[3.1.0]hex-3-en-2-ol; 2-methyl-5-(propan-2-yl)bicyclo[3.1.0]hex-3-en-2-ol; 83260-52-0; Bicyclo[3.1.0]hex-3-en-2-ol, 2-methyl-5-(1-methylethyl)-, (1.alpha.,2.alpha.,5.alpha.)-
|
|
CAS | 83260-52-0 | |
PubChem CID | 561870 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 152.23 | ALogp: | 2.0 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 11 | QED Weighted: | 0.573 |
Caco-2 Permeability: | -4.177 | MDCK Permeability: | 0.00003090 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.009 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.016 |
Blood-Brain-Barrier Penetration (BBB): | 0.989 | Plasma Protein Binding (PPB): | 62.76% |
Volume Distribution (VD): | 1.272 | Fu: | 45.22% |
CYP1A2-inhibitor: | 0.063 | CYP1A2-substrate: | 0.625 |
CYP2C19-inhibitor: | 0.15 | CYP2C19-substrate: | 0.869 |
CYP2C9-inhibitor: | 0.037 | CYP2C9-substrate: | 0.224 |
CYP2D6-inhibitor: | 0.046 | CYP2D6-substrate: | 0.184 |
CYP3A4-inhibitor: | 0.667 | CYP3A4-substrate: | 0.381 |
Clearance (CL): | 7.391 | Half-life (T1/2): | 0.382 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.059 |
Drug-inuced Liver Injury (DILI): | 0.032 | AMES Toxicity: | 0.008 |
Rat Oral Acute Toxicity: | 0.345 | Maximum Recommended Daily Dose: | 0.115 |
Skin Sensitization: | 0.08 | Carcinogencity: | 0.521 |
Eye Corrosion: | 0.006 | Eye Irritation: | 0.952 |
Respiratory Toxicity: | 0.106 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001145 | 0.400 | D06GIP | 0.184 | ||||
ENC002232 | 0.381 | D04CSZ | 0.184 | ||||
ENC000653 | 0.381 | D01CKY | 0.181 | ||||
ENC000872 | 0.349 | D07QKN | 0.173 | ||||
ENC002264 | 0.349 | D0A3HB | 0.167 | ||||
ENC005252 | 0.319 | D05VQI | 0.167 | ||||
ENC000360 | 0.319 | D0P0HT | 0.161 | ||||
ENC003268 | 0.298 | D0H1QY | 0.160 | ||||
ENC005117 | 0.298 | D08PIQ | 0.159 | ||||
ENC004312 | 0.288 | D0CW1P | 0.156 |